Sunzen Biotech Berhad reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was MYR 19.78 million compared to MYR 27.74 million a year ago. Net income was MYR 0.921 million compared to MYR 0.803 million a year ago. Basic earnings per share from continuing operations was MYR 0.0013 compared to MYR 0.0012 a year ago. Diluted earnings per share from continuing operations was MYR 0.0013 compared to MYR 0.0012 a year ago.
For the six months, sales was MYR 42.81 million compared to MYR 56.17 million a year ago. Net income was MYR 2 million compared to MYR 1.54 million a year ago. Basic earnings per share from continuing operations was MYR 0.0028 compared to MYR 0.0024 a year ago. Diluted earnings per share from continuing operations was MYR 0.0027 compared to MYR 0.0022 a year ago.